HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Mukae Selected Research

Diffuse panbronchiolitis

12/2022Interstitial Pneumonia with HLA-B54 Antigen that Responded Well to Erythromycin.
9/2010Differential effects of human neutrophil peptide-1 on growth factor and interleukin-8 production by human lung fibroblasts and epithelial cells.
1/2009Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin.
1/2007Telithromycin inhibits the number of viable bacteria but not lymphocyte accumulation in a murine model of chronic respiratory infection.
11/2006The expression of pro- and anti-apoptotic Bcl-2 family proteins in peribronchiolar lymphocytes from patients with diffuse panbronchiolitis.
3/2005Long-term macrolide antibiotic therapy in the treatment of chronic small airway disease clinically mimicking diffuse panbronchiolitis.
12/2004Efficacy of long-term macrolide antibiotic therapy in patients with diffuse panbronchiolitis: comparison between HLA-B54-positive and -negative cases.
4/2004Clinical similarities and differences between human T-cell lymphotropic virus type 1-associated bronchiolitis and diffuse panbronchiolitis.
10/2003Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis.
9/2003Overproduction of MUC5AC core protein in patients with diffuse panbronchiolitis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Mukae Research Topics

Disease

51Pneumonia (Pneumonitis)
10/2022 - 05/2002
42Infections
03/2022 - 05/2002
38Neoplasms (Cancer)
10/2022 - 09/2008
37Interstitial Lung Diseases (Interstitial Lung Disease)
12/2022 - 05/2004
28Lung Neoplasms (Lung Cancer)
01/2022 - 11/2004
25Idiopathic Pulmonary Fibrosis
11/2021 - 10/2004
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 07/2012
13Inflammation (Inflammations)
06/2022 - 03/2003
13Respiratory Tract Infections (Respiratory Tract Infection)
11/2021 - 11/2005
12Diffuse panbronchiolitis
12/2022 - 05/2002
12Human Influenza (Influenza)
09/2022 - 01/2008
12Respiratory Insufficiency (Respiratory Failure)
03/2022 - 07/2010
11Dyspnea (Shortness of Breath)
01/2022 - 10/2005
11Lung Diseases (Lung Disease)
11/2020 - 09/2003
10Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2022 - 10/2003
10Asthma (Bronchial Asthma)
04/2022 - 12/2009
9Communicable Diseases (Infectious Diseases)
01/2022 - 01/2013
9Fibrosis (Cirrhosis)
04/2020 - 10/2003
9Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
02/2018 - 09/2003
8Bacterial Pneumonia
04/2022 - 02/2008
8Hemorrhage
01/2022 - 01/2010
8Chronic Obstructive Pulmonary Disease (COPD)
05/2021 - 03/2002
7Cough
12/2022 - 10/2005
7Pleural Effusion (Pleural Effusions)
10/2022 - 01/2008
7Respiratory Tract Diseases (Respiratory Tract Disease)
03/2022 - 09/2004
7Pulmonary Tuberculosis
03/2022 - 02/2002
7COVID-19
01/2022 - 12/2020
7Neoplasm Metastasis (Metastasis)
12/2021 - 04/2012
7Healthcare-Associated Pneumonia
05/2020 - 10/2013
6Hypoxia (Hypoxemia)
10/2022 - 04/2006
6Disease Progression
04/2022 - 07/2012
6Vascular Diseases (Vascular Disease)
01/2022 - 07/2002
6Sarcoidosis (Schaumann Disease)
11/2020 - 10/2004
6Cryptogenic Organizing Pneumonia
04/2017 - 04/2007
5Chronic Renal Insufficiency
12/2022 - 09/2017
5Dermatomyositis (Dermatopolymyositis)
03/2022 - 09/2004
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 03/2017
5Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 07/2019
5Idiopathic Interstitial Pneumonias
01/2022 - 11/2008
5Liver Diseases (Liver Disease)
10/2021 - 01/2007
5Bronchiectasis
05/2021 - 07/2015
5Lung Injury
05/2021 - 07/2004
5Bronchiolitis
03/2019 - 04/2004
5Fever (Fevers)
04/2017 - 08/2009
4Pulmonary Aspergillosis
04/2022 - 01/2010
4Tuberculosis (Tuberculoses)
01/2022 - 05/2003
4Empyema
01/2022 - 01/2014
4Lymphoma (Lymphomas)
01/2022 - 09/2008

Drug/Important Bio-Agent (IBA)

30Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 05/2002
25Adrenal Cortex Hormones (Corticosteroids)IBA
05/2022 - 09/2003
22MacrolidesIBA
12/2022 - 05/2002
21Pharmaceutical PreparationsIBA
09/2022 - 10/2005
1816S Ribosomal RNAIBA
10/2022 - 01/2011
16Biomarkers (Surrogate Marker)IBA
07/2022 - 01/2005
14Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2002
14CollagenIBA
01/2022 - 07/2002
14Clarithromycin (Biaxin)FDA LinkGeneric
01/2021 - 05/2002
12SteroidsIBA
06/2022 - 01/2007
12EnzymesIBA
01/2022 - 05/2004
11AntigensIBA
12/2022 - 11/2002
10AntibodiesIBA
03/2022 - 08/2006
9CytokinesIBA
04/2022 - 03/2005
9Prednisolone (Predate)FDA LinkGeneric
01/2020 - 05/2004
8NivolumabIBA
07/2022 - 11/2017
7Oxygen (Dioxygen)IBA
06/2022 - 01/2011
7Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 08/2014
7Peptides (Polypeptides)IBA
05/2020 - 02/2002
7Bleomycin (Blenoxane)FDA LinkGeneric
12/2019 - 09/2008
6Erythromycin (Erycette)FDA LinkGeneric
12/2022 - 04/2003
6Immune Checkpoint InhibitorsIBA
07/2022 - 01/2018
6Immunosuppressive Agents (Immunosuppressants)IBA
06/2022 - 01/2014
6Biological ProductsIBA
01/2021 - 01/2013
6DefensinsIBA
03/2018 - 04/2007
6alpha-DefensinsIBA
09/2010 - 02/2002
5liposomal amphotericin BFDA Link
09/2022 - 10/2011
5InterleukinsIBA
04/2022 - 03/2003
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2022 - 01/2007
5C-Reactive ProteinIBA
03/2022 - 07/2007
5InterferonsIBA
01/2022 - 01/2015
5amrubicinIBA
01/2022 - 01/2019
5RNA (Ribonucleic Acid)IBA
11/2021 - 03/2010
5pirfenidoneIBA
11/2021 - 01/2008
5HSP47 Heat-Shock Proteins (Heat Shock Protein 47)IBA
01/2021 - 04/2007
5Protein Isoforms (Isoforms)IBA
07/2019 - 08/2014
5Immunoglobulin G (IgG)IBA
01/2019 - 06/2011
5ImmunosorbentsIBA
03/2018 - 10/2004
5Indicators and Reagents (Reagents)IBA
03/2018 - 10/2003
5beta-DefensinsIBA
02/2015 - 11/2004
4Oseltamivir (Tamiflu)FDA Link
09/2022 - 01/2008
4baloxavirIBA
09/2022 - 01/2021
4Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
03/2022 - 02/2015
4VaccinesIBA
01/2022 - 11/2002

Therapy/Procedure

62Therapeutics
12/2022 - 04/2003
23Drug Therapy (Chemotherapy)
01/2022 - 05/2004
9Renal Dialysis (Hemodialysis)
12/2022 - 01/2019
6Radiotherapy
01/2022 - 03/2011
5Activities of Daily Living (ADL)
10/2022 - 01/2011
5Transplantation
01/2022 - 01/2018
5Immunotherapy
01/2022 - 01/2018
4Aftercare (After-Treatment)
03/2022 - 10/2005